An observational study in Renal Failure, sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche. Recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-11-24.
Sponsored by GCS Ramsay Santé pour l'Enseignement et la Recherche · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 107 studies in Renal Insufficiency with a site in France — 13 open to participants now, 16 under way, none of them phase 3. Renal Insufficiency · France.
Among the 107 studies in Renal Insufficiency with a site in France, this one is the 10th largest by planned enrollment of the 39 observational ones that give a count, is one of 4 that started in 2025, is one of 39 observational ones, reaches primary completion later than 11 of the 15 other live ones, and was the 102nd registered.
1,415 studies on the registry are indexed under Renal Insufficiency; 149 are open to participants now.
Browse Renal Insufficiency studies →13 of the 107 studies in Renal Insufficiency with a site in France are open now. Recruiting first, the newest first:
Takeda · Sites in France, Belgium, Estonia and 4 more countries
Ages 18+
University Hospital, Strasbourg, France · Sites in France
Ages 18+
Hospices Civils de Lyon · Sites in France
Ages 6–17 · Men only
University Hospital, Lille · Sites in France
Ages 18+
Institut du Cancer de Montpellier - Val d'Aurelle · Sites in France
Ages 18+
A study can be open while its sites in France have not opened yet or have stopped. Only those recruiting at a site in France →
Of the 94 Renal Insufficiency studies recruiting now, 49 (52%) set no upper age limit and 19 (20%) stop at 75 or younger; 8 take children under 18; 15 take healthy volunteers.
This study: 18 Years and older · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
107 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 6 · Phase 2 10 · Phase 3 22 · Phase 4 8
First in 1994; this study’s year is marked. 4 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 544 is above the median of 178 across 294 observational studies indexed under Renal Insufficiency.
Median enrollment 108 across the 67 interventional studies, 186 across the 39 observational. Of the 75 that completed or were terminated, 14 (19%) have results posted.
This tab as a report to print or save as PDF → With an account.
31 of 107 have an industry lead sponsor. The 10 most frequent:
GCS Ramsay Santé pour l'Enseignement et la Recherche is the lead sponsor of 208 studies on the registry; 100 are open to participants now.
GCS Ramsay Santé pour l'Enseignement et la Recherche has 3 studies filed under Renal Insufficiency — fewer than ten, so there is no comparison to draw.
4 of the studies in Renal Insufficiency with a site in France that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07341516Paris Translational Research Center for Organ TransplantationWorldwide Assessment of Deceased Donor Kidney Utilization | 2026-11 |
| NCT07853677University Hospital, Strasbourg, FranceImpact of Extrarenal Myoglobin Clearance on Renal Recovery in Patients With Severe Rhabdomyolysis | 2026-12-31 |
| NCT04561362BicycleTx LimitedStudy BT8009-100 in Subjects With Nectin-4 Expressing Advanced Malignancies | 2027-01 |
| NCT06243731TakedaA Study of Maribavir in Adults With Kidney Failure Who Have a Cytomegalovirus (CMV) Infection After Transplantation | 2027-01-31 |
Add all 4 to your calendar (.ics) → With an account.
Among the 107 studies in Renal Insufficiency with a site in France, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of this study is to identify functional vascular changes and clinical factors correlated with the occurrence of short- or medium-term hand ischaemia after arteriovenous fistula creation.
This is a non-interventional, prospective, non-randomised, descriptive, single-centre study with no comparator.
The study population will be adult patients with chronic renal failure for whom an arteriovenous fistula has been planned.
Patients requiring the creation of an arteriovenous fistula by the surgeons at Hôpital Privé des Peupliers will be seen beforehand in the usual pre-operative consultation, during which the surgeon will explain the principle of the operation and the expected benefits/risks. On the day of surgery, patients will undergo the surgical procedure to create an arteriovenous fistula and will be discharged the same day. Patients will be reviewed during post-operative follow-up visits at 1, 6 and 12 months as in standard practice. All the data collected in the study were collected in routine medical practice.
The study population will be adult patients suffering from chronic renal failure for whom the creation of an arteriovenous fistula is planned.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Life expectancy
The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraception
Ways of preventing pregnancy. “Highly effective” methods fail less than 1% of the time a year when used correctly — for example an IUD or an implant.
Criteria usually say which methods count and how long to keep using them after the last dose, sometimes for male participants too. Some studies accept a partner’s vasectomy if it was confirmed successful and that person is the participant’s only sexual partner.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Adult patients with chronic renal failure for whom arteriovenous fistula creation is planned
Procedure: Creation of an arteriovenous fistula
Patients will undergo the surgical procedure to create an arteriovenous fistula and will be discharged the same day (outpatient care, or an overnight stay in hospital if they live a long way from the hospital, have multiple pathologies or are socially isolated). An arteriovenous fistula is created under local or general anaesthetic. On the day of the operation, the type of arteriovenous fistula created, the side of the arteriovenous fistula, the location of the arteriovenous fistula and the patency of the arteriovenous fistula will be collected.
Occurrence of ischaemia of the hand
Number and proportion of patients with ischaemia (Yes = stages 1, 2 or 3/No = stage 0) according to the preoperative American Vascular Surgery ischaemia classification : 0 - nothing 1. \- cold hand 2. \- pain on exercise and/or during dialysis 3. \- permanent pain, wound (ulceration, necrosis, gangrene)
Time frame: 12 months
Started Oct 2025 (actual). Primary completion is estimated for Dec 2027, 26 months after the start.
Of 88 non-industry observational studies under Renal Insufficiency, half reached primary completion within 29 months of starting (the median), counting those still running; a quarter within 14 and three quarters within 58. This study's planned 26 months is below that.
Counting every sponsor, half of 103 studies reached it within 30 months; a quarter within 14 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
GCS Ramsay Santé pour l'Enseignement et la Recherche →